Graves' disease and hyperthyroidism trials in Hungary
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Pécs
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627 - Phase 2Enrolling by invitationA Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
- Where
- Pécs
- Age
- 18 years and over
- People
- 372 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07286006 - Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Békéscsaba, Budapest III, Budapest VIII, Debrecen, Pécs, Szeged
- Age
- 18 years to 75 years
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - Phase 2Taking peopleA Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
- Where
- Békéscsaba, Budapest III, Budapest VIII, Debrecen, Pécs, Szeged
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to join2025-524001-33-00